Browse by Audience
Skip to content
Papers of the Week
CGRP Antagonists for the Treatment of Chronic Migraines: a Comprehensive Review.
Authors
Abstract
The purpose of the following review is to summarize the most recent understanding of migraine pathophysiology, as well as of basic and clinical science pharmacologic literature regarding the development of calcitonin gene receptor peptide (CGRP) antagonists as a novel therapeutic modality for the treatment of migraine headaches. A review is provided of erenumab, the first of its class FDA approved CGRP antagonist.